Drugs Made In America Acquisition II Corp. operates as a blank check company. The company is headquartered in Fort Lauderdale, Florida. The company went IPO on 2025-09-25. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The firm intends to search for business combination targets in the pharmaceutical industry. The firm is neither engaged in any operations nor generated any revenues.
DMIIU stock price ended at $10.13 on 星期二, after rising 0.90%
On the latest trading day Feb 10, 2026, the stock price of DMIIU rose by 0.90%, climbing from $10.13 to $10.13. Throughout the session, the stock experienced a volatility of 0.00%, with prices fluctuating between a daily low of $10.13 and a high of $10.13. Alongside this price increase, trading volume also rose by 86 shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 348 shares were traded, amounting to a market value of approximately $664.3M.